Life Sciences

EFPIA Leads the Self-Regulation Charge to Try to Avoid Government-Imposed Transparency

7/24/2013 | Article

By D. Jeffrey Campbell and Brian P. Sharkey

As the worldwide trend toward government‐imposed transparency in the relationships between life sciences companies and healthcare professionals accelerates, the pharmaceutical industry is aggressively pursuing a different tactic: self‐regulation. While advocates of legislative intervention argue that government‐imposed disclosure requirements will decrease the cost of drugs and reduce corruption, supporters of self‐regulation stress that their approach can lead to world‐wide uniformity and a much more manageable, logical, and efficient path to transparency. As the argument between advocates of government action and supporters of industry self‐regulation flares, the pharmaceutical industry is seeking to gain the upper hand by enacting self‐regulatory transparency measures in a number of key jurisdictions.

More >